STUDY OF CYTOKINE STATUS IN PATIENTS WITH Β-THALASSEMIA.
Abstract
Thalassemia is a disorder of the synthesis of one or more globin chains, a heterogeneous group of diseases in which the production of normal hemoglobin in the body is partially or completely inhibited and severe anemia develops [1-3]. Clinically important and most common types are α-thalassemia (D56) and β-thalassemia (D56.1). Globin β thalassemia with impaired synthesis of -chain β-called thalassemia. This type of thalassemia is more common than others. With α-thalassemia, the synthesis of α-chain is disturbed. Also described are cases of γ- and δ-thalassemia, in which the synthesis of globin chains of the same name is disturbed.
References
Asadov Ch.D., Ragimov AA Immunologicheskie narusheniya pri b-thalassemia (obzor literatury) // Vestn. slujby krovi Rossii. – 2011. – No. 1. - S. 37-42.
Volkova SA, Borovkov NN // Basic clinical hematology: Ucheb. posobie. - M., 2013. - 400 p.
Krasilnikova MV, Lokhmatova ME, Smetanina NS // Hematology, oncology and immunopathology and pediatrics. – 2009. – No. 1. - S. 43-46.
Rukovodstvo po klinicheskomu lecheniyu thalassemia. - 2nd izd. - M., 2007. - 203 p.
Rumyantsev AG, Tokarev Yu.N. Indications for peregruzka chelatornaya therapy. - M., 2015.
Sisl B. Management of laboratory hematology/, 2011. – 352 p.
Abetz L., Baladi J.-F., Jones P., Rofail D. The impact of iron overload and its treatment on quality of life: results from a literature review // Health Qual. Life Outcomes. - 2006. - Vol. 4. – P. 73.
Kushner JP, Porter JP, Olivieri NF Secondary iron overload // Hematol. Amer. Soc. Hematol. Educ. Program. - 2010. - Vol. 45. – P. 47-61.
